Ellisa Cholapranee joined NeoGenomics as General Counsel in September 2026 and is responsible for the company’s legal function. She brings over two decades of legal experience across healthcare, life sciences, and medical technology, advising organizations through growth, transformation, and complexity.
Most recently, Ellisa served as General Counsel, Corporate Secretary and Compliance Officer at ClearPoint Neuro, where she built the legal and compliance function as the company grew into a global platform partnering with biopharma to deliver cell and gene therapies to the brain. There she led corporate governance and securities matters, financing and M&A transactions, commercial contracting, and the development of the company’s compliance and intellectual property programs. Earlier in her career, Ellisa held senior legal roles at Philips and MilliporeSigma. She began her career in the corporate departments of national law firms, advising on strategic transactions.
Ellisa earned a Bachelor of Science in Mathematics from Carnegie Mellon University and her JD from Northwestern University Pritzker School of Law.